September 2017
In this Issue
Advocate for Medicine
Issue
Supplement
NEWS
The FDA File
COVER FOCUS
In-Focus: Advocate for Medicine
Can the Private Practice Survive in the Age of Consolidation?
In the rapidly changing health care economy, increasing regulation and the expanding influence of third-party payers are diminishing the physician’s role.
By Pavel Klein, MD
Rising Drug Prices and the Cost of Care: What Can Physicians Do?
The multiple sclerosis drug market offers a snapshot of a growing problem. Physicians should speak out on behalf of the specialty and their patients.
By Dennis Bourdette, MD
NeuroAdvocacy: Why Lobbying Matters
Advocating for patients and the specialty is a powerful way for physicians to make their voices heard.
By Janice F. Wiesman, MD
Legislative Update: The Future of MACRA
With a proposed rule change currently under consideration, one expert assesses the impact and the future of the new law.
With Lyell K. Jones, Jr., MD
FEATURE ARTICLES
Tics and Tourette Syndrome
Recognizing the full spectrum of phenomenology of tics and various behavioral comorbidities is critical to diagnosis.
By Joseph Jankovic, MD
Aches and Trauma: Understanding Post-Traumatic Headache, Part 2: Management and Treatment
Despite limited options for the treatment of post-traumatic headache, some evidence suggests potential for select therapies.
By Francis X. Conidi, DO, MS
VIDEO CASE CHALLENGE
Chronic Facial Weakness and Deafness
By Hamzah Lateef, MD; Rozeen Badeel, MD; and Aziz Shaibani, MD
FINANCIAL PLANNER
Seven Reasons to Review Your Life Insurance Plan
Life insurance plans cannot be refinanced like mortgage plans, but they can be replaced.
By Jason M. O’Dell, MS, CWM and Andrew Taylor, CFP
Top 5 Articles From September 2017
Aches and Trauma: Understanding Post-Traumatic Headache, Part 2: Management and Treatment
Despite limited options for the treatment of post-traumatic headache, some evidence suggests potential for select therapies.
By Francis X. Conidi, DO, MS
Tics and Tourette Syndrome
Recognizing the full spectrum of phenomenology of tics and various behavioral comorbidities is critical to diagnosis.
By Joseph Jankovic, MD
Rising Drug Prices and the Cost of Care: What Can Physicians Do?
The multiple sclerosis drug market offers a snapshot of a growing problem. Physicians should speak out on behalf of the specialty and their patients.
By Dennis Bourdette, MD
NeuroAdvocacy: Why Lobbying Matters
Advocating for patients and the specialty is a powerful way for physicians to make their voices heard.
